Clinical Trial Update: A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of ustekinumab in patients with primary biliary cholangitis who had an inadequate response to ursodeoxycholic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Primary Biliary Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2014-10-15